Arcturus Therapeutics has partnered with Israel in a deal reportedly worth hundreds of millions of dollars to begin clinical trials on humans in Singapore for its COVID-19 vaccine.

Arcturus Therapeutics has partnered with Israel in a deal reportedly worth hundreds of millions of dollars to begin clinical trials on humans in Singapore for its COVID-19 vaccine.

Arcturus Therapeutics, has announced positive interim clinical study results from its ongoing Phase 1/2 study of ARCT-021, its vaccine candidate for COVID-19...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99